Clinical Trial Update: Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update showing superiority of newly developed echinacea formulations over basic formulations for respiratory tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Snippet

Sponsor: A. Vogel AG | Conditions: Respiratory Tract Infections | Phase 2, Phase 3 | Status: COMPLETED